<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 141 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page140.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=141">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 141 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 141</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=141"><img src="../thumb/141.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>110 / 2020-04                                                        Cardio-Vascular Agents - 7.3.8
   interv.are a torsades de pointes risk with non-anti-/arrhythm. drugs   Indications: Hypertens.requir.fix.combinat.ther.  Dosage: Mild to mod.hypertens: 4 mg dly.bef. breakf., may be
   prolong QT interv./meds.caus.torsade de pointes, incr.creatin.lev.risk   (S3) TABS. .34/7.1.3/0190  incr.to 8 mg as sngl.dos.aft.1 mnth. of treatm.
          +
   with cyclospor., K low. drugs/IV amphotericin B/glucocortic./ miner-  885019-005: 30, R106,26  CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once
                         +
   alocortic./stimul.laxat./tetracosactide, incr. risk of low K lev.effs., cor-  Dosage: 1 tab dly. May be incr.to 2 tabs.dly.  BP accept.
   ticoster.& tetracosactide reduc. antihypertens.eff., card. glycosides   Contraindications: Anur., sulphonamide sens., angioed.hist.with   CV event risk reduct: Init.4 mg once dly.x2wks. incr.to 8 mg once
   tox.effs.fav.by low.K lev.   ACE inhibit./angiotens.recept. block., heredit./idiopath.angioed., aort.  dly.depend.on ren.funct.
           +
   PERINDOPRIL UNICORN, (Unicorn) Biogaran [P/S]  stenos., hypertroph.obstruct. cardiomyopathy, sev.ren. funct.impairm.,   Contraindications: Pregn., lactat., childr., other ACE inhibit.sen-
                                                              sitiv., angioed.hist.assoc.with prev. ACE-inhibit.ther., heredit./idi-
                                ren.artery stenos.with sngl.kidn., concom.K -spar.diuret., porphyr., Ad-
                                                  +
   Perindopril tertbutylamine   dison’s dis., Li ther., safety & effic.in childr.not est., pregn.& lactat.  opath.angioed.
   Indications: Mild to mod.hypertens., CHF not adeq. control.with   Side effects: Dizzin., fatig., impot., musc.cramps, GI disturbs., hy-  Side effects: CNS effs., paraesthes., mood/sleep disturbs., vis.
   diuret.& digital.& where vasodilat. indicat  potens., aesthen., headache, cough, CV effs., CNS effs., dyspn., skin   disturbs., tinnit., hypotens., arrythm., ang. pect. MI & stroke poss.
   (S3) TABS, 37/7.1.3/0021, 38/7.1.3/0121  reacts., ren. dysfunct./fail., dry mouth, gout, tinnit., arthralg., angio-  second.to excess. hypotens., cough, dyspn., bronchosp., eosinophil.
   717783-001: 4 mg, 30, R77,70  neurot.oed., pancreatit., hepatit., sore throat, hoarsen., rhinorrh., MI/  pneumon., rhinit., GI disords., dry mouth, pancreatit., hepatit., rash,
   717784-001: 8 mg, 30, R125,59  CVA, photosens., alopec, flush., blurr.vis., bld.disords., sialoadenit.,   prurit., angioneurot.oed. of face/extremit./lips/tong./glottis & larynx.,
   Dosage: Mild to mod.hypertens: 4 mg dly.bef. breakf. may be   fev., resp.distress, anaphylax., glycosur., electrol. imbal., hyperuri-  urticar., erythema multiforme, musc.cramps, ren.insuffic.& ac.ren.fail.,
   incr.to 8 mg as sngl.dos.aft.1 mnth. of treatm. Discont.concom.  caem., hyperglycaem., SLE activ./ exacerbat.  impot., asthen., sweat., bld.dyscras., haemolytic.anaem.in congenit.G-
   diuret.bef.init.ther.        Special precautions: Ischaem.heart/ cerebrovasc. dis.as excess.  6PDH defic., hyperkalaem.
   CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once   fall in BP could result in MI/ CVA, concom.diuret., imp.hepat.funct.,   Special precautions: Hypotens.in HF pts., pass.through placenta,
   BP accept.                   progress. liv.dis, ren.impairm., monit.fluid & electrol. bal., surg./  discont.ther./switch to diff.meds.if pregn.occurs./pregn.contempl., ren.
   Contraindications: Pregn., safety in childr.& dur.lactat. not est.  anaesth., diabet., angio-oed. unrelat. to ACE-inhibit. may incr.the   insuffic., elderly., vol.&/salt deplet.pts., monit.of concom.K -spar.diu-
                                                                                      +
   Side effects: Psych./CNS effs., headache, dizzin., vertigo, paraes-  angio-oed.risk when tak.ACE-inhibit., poss.life-threaten. anaphylact.   ret./K  supplem./K  salt substit. / meds.assoc.with incr.ser. K  & Li if
                                                                +
                                                                                       +
                                                                      +
   thes., vis. disturbs., tinnit., hypotens., arrhythm., ang.pect., MI, stroke,   reacts.in pts.being desensitis.with hymenoptera venom, concom.   ther.necess., Li toxic.risk incr.with thiazide diuret., ischaem. heart dis.,
   cough, dyspn., bronchosp., eosinophil.pneum., rhinit., GI disords., dry   ganglion./adrenerg. block. agents., lact.intol.  cerebrovasc.dis., concom.diuret.ther., consid.reduc.dos./discont.ther.if
   mouth, pancreatit., hepatit., angioed., skin reacts.incl.erythema multi-  Drug interactions: Thiaz.ther.may imp.gluc.tol., thiaz. may decr.urin.  hypotens. becomes symptomat.in CHF pts., mitral valve stenos., aort.
   forme, musc. cramps, ren.insuff., ac.ren.fail., impot., asthen., sweat.,   Ca excret., K losing eff.of thiaz. diuret.dimin.by enalapril eff., K -spar.  stenos./hypertroph.cardiomyopathy, bilat./solitary ren.artery stenos.,
                                                          +
   bld.dyscras., hyperkalaem.   agents/ K contain.salt substit/K supplem.may incr.ser.K, reduc. Li ren.  haemodialys.with high flux membr., incr.angioed.incid.in black pts.,
                                             +
                                    +
   Special precautions: Pass.through placenta, discont.ther./ switch   clear., thiaz.incr.responsiven.to tubocurarine, alcoh., barbits.& narcot.  angioed.hist.poss.incr.angioed.risk, anaphylact. reacts.dur.low.den-
   to diff.meds.if pregn.occurs, alter. meds.if pregn.contempl., monit.with   may potent. orthostat. hypotens., cortico-ster.& ACTH intens. elec-  sity lipoprot.apheres.with dextr. sulph.& hymenoptera desensitisat.
             +
       +
   concom. K -spar.diuret./K  supplem./K  salt substit./Li lev., concom.  trol. deplet., NSAIDs may reduc.diuret./ natriuret. & antihypertens.  treatm., discont. ther.if jaund./elev.hepat.enzym.noted in collag. vasc.
                   +
   sympathomimets., ren.insuffic., monit. ren. funct.esp.dur.1  wks.of   eff., respon.to press. amines poss.decr.  dis./ immunosuppress.ther./allopurinol/ procainamide ther.esp.in pres.
                           st
   ther., CF, discont.ther.& appropr. treatm.if ser.hypersens.reacts.occur,   of ren.fail.monit. WBC. & pt.to report infect., consid.ACE-inhibit. induc.
   hypovolaem., hyponatraem., pre-exist.hypotens., unstab. CF, concom.  PRETERAX, Servier  cough as different.cough diagnos., surg./ anaesthes., diabet.mellit.
   high-dos.vasodilat.ther., pts.≥ 70 yrs., diet.salt restrict., dialys., diarrh.,   Perindopril tert-butylamine salt 2 mg, indapamide 0,625 mg.  Drug interactions: Excess.BP reduct.with diuret., hyperkalaem.
   vomit., anaphylact. reacts.dur.hymenoptera desensitisat. treatm., hae-  Indications: Mild to mod.hypertens  with K -spar.diuret./K  supplem./K  salt substit., ser.Li incr.& Li
                                                                        +
                                                                 +
                                                                             +
   modialys.with high flux membr., sev. liv. funct.impairm., proteinur.esp.  (S3) TABS, 33/7.1.3/0362  toxic.risk incr.with concom.thiaz.diuret., antihypertens.eff. reduc.by
   with high dos./ exist. ren.funct.impairm., WBC monit.esp.in collag.   700512-001: 30, R263,63  NSAID’s & sympathomimet., NSAID’s have addit. eff.on ser.K  incr.,
                                                                                        +
   vasc.dis./ concom.immunosuppress.ther., maj.surg. / anaesthes., incr.  Dosage: 1 tab.as sngl.dly.dos.pref.in morn. Dos. may be doubl.to   hypotens.eff.incr.by other antihypertens./nitroglycer/other nitrates/
   sev.hypotens./ren.insuffic risk in renovasc. hypertens./pre-exist.bil.&   2 tabs.if BP not adeq.control.
                                                          +
   unilat.ren. art.stenos., ther.to be init.in hosp.in case of renovasc. dis.,   Contraindications: Angioneurot.oed., not recomm. with K -spar.  other vasodilat./ cert.anaesthet./TCA’s & antipsychot., bld. gluc.low.
                                                              eff.of antidiabet.meds.incr.
   renin-angiotens.-aldoster.syst.  diuret./K  salts/Li/in bilat. ren. artery stenos/sngl.funct.kidn/in elev.
                                    +
                                 +
   Drug interactions: Hypotens.eff.incr.by other antihypertens. esp.   K ser. lev. in combinat.with non-antiarrhythm.agents caus. torsades   PREXUM PLUS, Biogaran
   when combin.with diuret., eff.potent. if hypovolaem. poss.occurs,   de pointes, pregn., lactat., childr., sulphonamide hypersens, sev.ren.  Perindopril arginine salt 5 mg, indapamide 1,25 mg
   poss. hyperkalaem. with K supplem./K  salt substit./K -spar.diuret.,   fail.(creatinine clear.&lt;30 ml/min), hepat.encephalopathy, sev.liv.   Indications: Mild to mod.hypertens.
                   +
                         +
              +
   ser.Li incr., poss.post.hypotens. with narcot./ antipsychot., poss.an-  impairm., hypokalaem., dialysis, untreat. decompensat. heart fail.  (S3) PREXUM 5 mg PLUS TABS, 42/7.1.3/0168
   tihypertens.eff. with sympathomimets., poss. incr.hypoglycaem.eff.   Side effects: CNS effs., asthen., hypotens., skin rash, GI disturbs.,   720388-001: 30, R91,50
   with insul./sulphonylur.     dry cough, angioneurot.oed., hepat.encephalopathy in hepat.insuf-  Dosage: Indiv.dos.titrat.with indiv.compon. recomm.
                                fic., hypersens. reacts., GI disturbs., pancreatit., hypokalaem. partic.
   PHARMAPRESS, (Aspen Pharmacare:    in diabet./ren.fail.pts., cramps, paraesthes., dehydrat.due to reduc.  Admin.1 tab./day as sngl.dos.pref.in morn.bef.meal
   Pharma) Pharmacare [P/S]     sod. lev., bld.dyscras., electrol.disturbs., precipitat. second. gout, ren.  (S3) BIOPREXUM PLUS TABS 10/2,5, 43/7.1.3/0971
                                                              Perindopril arginine salt 10 mg, indapamide 2,5 mg
   Enalapril mal.               fail.partic.with sev.HF./underly. ren.fail., Ca eliminat.reduc.rais.Ca lev.
   Indications: Hypertens., CHF in combinat.with diuret.& digital.,   Special precautions: Pass.through placenta, excret. in breast milk,   Indications: Hypertens.where pt.stabil.on indiv. compon.at same
                                                              dos.range & in pts.not adeq. contr. on monother.of indiv.compon.
   asymptomat.L ventric.dysfunct.  assess neutropaen.risk: benef. rat.in ren.impairm.with collag.vasc.
   (S3) TABS, A38/7.1.3/0640, 33/7.1.3/0479, 0480  dis & immunosuppress.ther., desensitat.ther.with wasp/ bee venom   721508-001: 30, R142,32
                                                              Dosage: 1 tab./day as sngl.dos.pref.in morn.bef. meal
   708109-001: 5 mg, 30, R39,20  & high-flux membr./low density lipoprot. apheres.with dextrane   (S3) PREXUM 2,5 PLUS TABS, 42/7.1.3/0165
   868914-002: 10 mg, 30, R53,85  sulph.used in haemodialys may induc.anaphylact.reacts., imp. liv./
   868922-005: 20 mg, 30, R97,04  ren.funct., gout, diabet.mellit., ren.artery stenos., CHF, cirrhos.with   Perindopril arginine salt 2,5 mg, indapamide 0,625 mg
                                                              Indications: Mild to mod.hypertens.
   Dosage: Indiv.               oed.& ascites, electrol. disturbs., monit. K & Na lev., elderly, ischaem.
                                                 +
   Essent.hypertens: Init.10-20 mg dly. Maint: 20 mg dly. Full thera-  heart dis., grade IV card.insuffic., cerebr.circulat. insuffic., monit.Hb   Dosage: 1 tab.dly.as sngl.dos.pref.in morn.bef. meal
                                                              721507-001: 30, R102,49
   peut.eff.aft.sev.wks.theref.if desir.eff.not achiev.within 2-4 wks.  lev.in kidn.transpl.& dialys. pts., discont.2 days prior to surg.if poss.,
   dos.may be incr.             aort. stenos./ hypertroph.cardiomyopathy, long QT interv., correct hy-  (S3) PREXUM PLUS TABS, 38/7.1.3/0028
                                                              Perindopril tertbutylamine salt 4 mg, indapamide 1,25 mg
   Renovasc.hypertens: Init.5 mg or less. Most pts.respond.to   pokalaem. as it favours onset of sev. arrhythm, avoid QT prolong.non
   20 mg dly.                   antiarrhythm. drugs, rehydrat.prior to use of iodinat. contrast media.  Indications: Essent.hypertens.not adeq.control. & where fix.com-
                                                              binat.is consid.more approp.than monother.
   HF/asymptomat.L.ventric.dysfunct: Init. 2,5 mg dly.incr.grad.  Drug interactions: Hypokalaem.incr.card.toxic. of card.glycos.&
   to usual maint.dos.of 20 mg as sngl. dos./2 div.dos.as tol.titr.over   arrythm.risk, Li lev.incr., hypoglycaem. eff.of insulin & hypoglycaem.   704929-001: 30, R174,27
   a period of 2-4 wks.         sulphonam. incr., baclofen/TCA’s/neurolept./ anaesthet. agents &   Dosage: Indiv. 1 tab.dly.pref.in morn.bef.meal
                                                              Contraindications: Prior ACE-inhibit./ sulphonamid. sens., angioed.
   Contraindications: Angioed.hist.with ACE inhibit. / angiotens.re-  antihypertens.potent. antihypertens. eff., corticoster.& tetracosactide
   cept.block., heredit./idiopath. angioed., aort.stenos., hypertroph.ob-  reduc. antihypertens.eff., K  spar.diuret.incr.K  lev. NSAID’s & high dos.  hist.link.to prev.ACE inhibit./ARB ther., heredit./idiopath.angioed.,
                                           +
                                                  +
                                                              aort.stenos., hypertroph.obstruct.cardiomyopathy, porphyr., pregn.,
   struct. cardiomyopathy, sev.ren.funct.impairm., ren.artery stenos.with   salicylate poss.reduc. antihypertens. eff., allopurin./cytostat./ immu-  +
   sngl.kidn., concom.K -spar.diuret., porphyr., safety & effic.in childr.not   nosuppress. agents/system.corticoster.& procainamide incr.leucopen.  lactat., concom.Li/K salts/-supplem./-spar.diuret., bil.ren.artery
           +
                                                              stenos., ren. artery stenos.in pts with singl.kidn., sev.ren. impairm.,
   est., pregn., safety in lactat.not est.  risk, K  low.drugs have addit,K  low.eff., non-arrhythm./anti-arrhythm.    +
                                   +
                                             +
   Side effects: Angio-oed., bld.dyscras., orthostat. effs., CNS effs.,   drugs which prolong QT interv./cause torsades de pointes as low K+   elev.K ser.lev., concom.aliskiren in pts. with diabet.mellit./ren.im-
                                                              pairm., hepat. encephalopathy, sev.hepat.impairm., hypokalaem., in
   paraesthes., hyperkalaem., hyponatraem., incr.bld.urea & ser.crea-  lev.are a risk fact. for torsades de pointes, lact.acidos.with metform-
   tin., GI disturbs., pancreatit., ren.dysfunct., impot., hepatit., asthen.,   in, reduc.urin. Ca eliminat.poss.incr.Ca lev. with Ca salts, cyclospor.   combin.with non antidysrhythm.agents caus. torsades de pointes,
   cough, bronchosp., rhinit., sinusit., skin reacts.incl.tox.epiderm.  may incr.creatinine lev.  Addison’s dis., anur., dialys. pts., untreat.decompens. HF., effic.in
   necolys./Stev. Johnson.& erythem. multiforme, hypersens.reacts.,   childr.& adolesc. not est., lact.intol.
   sympt. complex.incl.fev./vasculit./myalg./+ANA / elev.ESR,/rash/  PREXUM, Biogaran [P/S]  Side effects: Bld.dyscras., angioed.of face/ extremit./ lips/tong./
   photosens.& derm.reacts.     Perindopril arginine salt     glottis & larynx., urticar., mood/ sleep disturbs., CNS effs., paraes-
   Special precautions: Cerebrovasc.dis./ischaem. heart dis., vol.de-  Indication: Mild to mod.hypertens., CHF not adeq. control.with diu-  thes., dysgeus., vertigo, confus., vis.disturbs., tinnit., hypotens., dys-
                                                              rhythm. incl.bradycard./ventric. tachycard./atrial fibrillat., ang.pect.,
   plet., pts.at high risk of symptomat. hypotens.should have condits.  ret.& digital.& where vasodilat. indicat.,
   correct. bef. init.ther., sev.autoimmune dis., ren.dysfunct., ren. trans-  (S3) PREXUM 5 mg TABS., A39/7.1.3/0232  stroke/MI second.to excess.hypotens.in high risk pts., vasculit., dry
                                                              cough, dyspn., bronchosp., eosinophil. pneumon., rhinit., decr.appet.,
   plant, ac.MI pts.with ren.dysfunct.or at risk of furth.haemodynam.  720387-001: 5 mg, 30, R77,70
   detiorat. aft.vasodilat. treatm., bone marr.depress., diab.mellit., hyper-  Dosage: Mild to mod.hypertens: 5 mg dly.bef. breakf., may be   hypercalcaem., GI disords., dry mouth, pancreatit., hepatit., hepat.en-
   kalaem., spec.supervis.if admin.in sev.resist. hypertens.in renovasc.  incr.to 10 mg as sngl.dos.aft.1 mnth. of treatm.  cephalopathy in pres. of hepat. insuffic., rash, prurit., maculopapul.
   dis., anaphylact.reacts.exp. in pts.on ACE inhib.being desensitis.with   CHF: Init. 2,5 mg as sngl.dos.in morn., may be incr.to 5 mg once   erupt., erythem. multiform., tox.epiderm.necrolys., Stev. Johns.syndr.,
   hymenoptera venom or in haemodialys.using cert. high-flux membr./  BP accept.  photosens., pemphigoid., hypersens. reacts.main.dermatolog., pur-
   low density lipoprot.apheres. with dextr.sulfate, discont.ther & instit.  (S3) PREXUM 10 mg TABS. [P/S] A39/7.1.3/0233  pura, malais., musc. cramps, ren.insuffic.& ac.ren.fail., ED., asthen.,
   appropr. emerg. ther.in case of angioed./laryng.oed., black pts. have   Perindopril arginine salt.  fatig., sweat., hypokalaem., hypoglycaem., hyponatraem., hypovol-
                            +
                 +
   high.incid.of angio-oed., concom.K -spar. diuret., monit.ser.K , cross.  Indication: Mild to mod. hypertens.  aem., precipitat.of second. gout, hyperkalaem., pyrex., fall, periph.oed.
   placenta, ideally discont. concom.diuret.ther.2-3 days bef.init.ther.,   714646-001: 10 mg, 30, R125,70  Warnings and special precautions: Pass. through the placenta,
                                                              discont.ther./switch to diff. meds.if pregn.occurs./pregn.contempl.,
   maj. surg., anaesth., lact.intol.  Dosage: Mild to mod.hypertens: 5 mg dly.bef. breakf., may be
   Drug interactions: Incr.agranulocytos.& neutropen. risk with immu-  incr.to 10 mg as sngl.dos.aft.1 mnth. of treatm.  incr risk of hypotens./hyperkalaem./decr.ren.funct.with concom.
   nosuppress., addit. antihypertens. eff.with diuret./alcoh.& hypotens.   (S3) PREXUM TABS, 36/7.1.3/0020  ARB/aliskiren ther.concom.ARB ther.in pts. with diabet.nephropa-
   produc. meds., indomethac.& NSAID’s reduc. antihypertens. eff., hy-  Perindopril tertbutylamine salt.  thy, risk:benef.eval.with collag.vas. dis./immunosuppress.agents,
   perkalaem.with K supplem./ K spar. diuret., ser.Li lev.incr.  Indications: Mild to mod.hypertens., CHF not adeq. control.with   discont. immed.in case of angioed.&init.approp.ther., angioed. hist.
               +
          +
                                diuret.& digital.& where vasodilat. indicat., CV event risk reduct.in   poss.incr.angioed.risk, incr.angioed. incid.in black pts., consid.intestin.
   PHARMAPRESS CO, (Aspen Pharmacare: Pharma) Pharmacare  stable coron. artery dis.without HF.  angioed.as different.diagnos.of present.abdom.pain, anaphylact. re-
   Enalapril mal. 20 mg, hydrochlorothiaz. 12,5 mg.  703541-003: 4 mg, 30, R137,45  acts.dur.low.density lipoprot. apheres. with dextr.sulph./haemodialys.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page140.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page136.html">136</a>&nbsp;&nbsp;&nbsp;<a href="page137.html">137</a>&nbsp;&nbsp;&nbsp;<a href="page138.html">138</a>&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>
             </td>
             <td width="35%"><a href="page142.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page142.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
